Skip to Content

Month: April 2023

Hungary’s Orban calls US a ‘friend’ despite sanction on bank

By JUSTIN SPIKE Associated Press BUDAPEST, Hungary (AP) — Hungary’s prime minister is seeking to bring down the temperature on spiraling tensions between his government and the United States after Washington sanctioned a Hungary-based Russian bank. Viktor Orban said on Friday that the U.S. was Hungary’s “friend” and that his government wouldn’t dispute Washington’s right

Continue Reading
Nuevo gobierno se acerca a UABC

MLS suspende al jugador de los Red Bulls de Nueva York por 6 juegos por usar un insulto racial durante un partido

Melissa Velásquez Loaiza (CNN) — El delantero de los Red Bulls de Nueva York, Dante Vanzeir, fue suspendido por seis partidos de la temporada regular luego de usar un insulto racial durante el partido del sábado en la Major League Soccer (MLS) contra los San Jose Earthquakes, anunció la liga. Vanzeir también será multado por

Continue Reading

JPMorgan Chase reports record revenue

By Krystal Hur and Nicole Goodkind, CNN JPMorgan Chase on Friday reported first-quarter profit and revenue that roundly beat expectations. The New York-based bank posted a profit of $12.6 billion or $4.10 per share. That’s up from $8.3 billion, or $2.63 per share from the same period a year before, or 52%. Analysts expected earnings

Continue Reading

The American consumer has bad news for the economy

CNN By Nicole Goodkind, CNN The strength of the US economy rests on the shoulders of consumers. If people are spending money, companies keep employees in their jobs … and those workers keep spending. In theory, anyway. Consumer spending accounts for about 70% of America’s gross domestic product, the broadest measure of the economy, so

Continue Reading

Wells Fargo: Q1 Earnings Snapshot

SAN FRANCISCO (AP) — SAN FRANCISCO (AP) — Wells Fargo & Co. (WFC) on Friday reported first-quarter profit of $4.99 billion. The San Francisco-based bank said it had earnings of $1.23 per share. The results beat Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of $1.15

Continue Reading

Texas abortion drug ruling could create ‘slippery slope’ for FDA approvals, drug research and patients, experts say

By Jen Christensen, CNN What happened in one judge’s courtroom in Texas could have drastic effects for the United States’ entire drug approval process, experts warn. US District Judge Matthew Kacsmaryk’s ruling that suspended the US Food and Drug Administration’s approval of the medication abortion drug mifepristone was an unprecedented one, the first time a

Continue Reading